# Evaluate the Impact, Safety, Tolerability and Immunogenicity of the Coronavac Vaccine in Kidney Transplant Recipients

> **NCT04801667** · PHASE4 · UNKNOWN · sponsor: **Hospital do Rim e Hipertensão** · enrollment: 3371 (actual)

## Conditions studied

- SARS-CoV Infection
- Coronavirus Infection
- Vaccine Adverse Reaction

## Interventions

- **BIOLOGICAL:** Coronavac

## Key facts

- **NCT ID:** NCT04801667
- **Lead sponsor:** Hospital do Rim e Hipertensão
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-20
- **Primary completion:** 2021-10-01
- **Final completion:** 2023-03-01
- **Target enrollment:** 3371 (ACTUAL)
- **Last updated:** 2022-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04801667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04801667, "Evaluate the Impact, Safety, Tolerability and Immunogenicity of the Coronavac Vaccine in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04801667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*